Manchester Capital Management LLC Merrimack Pharmaceuticals Inc Call Options Transaction History
Manchester Capital Management LLC
- $802 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MACK
# of Institutions
70Shares Held
9.18MCall Options Held
64KPut Options Held
3.2K-
Western Standard LLC Los Angeles, CA2.17MShares$32.9 Million15.49% of portfolio
-
Newtyn Management, LLC New York, NY1.87MShares$28.3 Million5.97% of portfolio
-
Adar1 Capital Management, LLC Austin, TX902KShares$13.7 Million3.02% of portfolio
-
Black Rock Inc. New York, NY723KShares$10.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA621KShares$9.39 Million0.0% of portfolio
About MERRIMACK PHARMACEUTICALS INC
- Ticker MACK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,410,200
- Market Cap $203M
- Description
- Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.